Understanding and adapting the educational method to your innovative projects is the core focus of our executive programmes for organisations. We design solutions for the challenges that an early-stage project in the Life Sciences industry faces when focusing to a business and management mindset.
Our programmes are directed by our senior level of experiences professionals, lecturers and advisors with a wide experience in the global understanding of the Life Sciences Industry, the pharmaceutical industry, and the biotechnology sector including healthcare, medical devices, and digital health organisations among others.
Our collaborations are oriented to an immediate application of the learning programmes towards international business development centred on the portfolio opportunities and potential products. The result is always a talented team focus and driven to develop the innovation strategy oriented to a global commercialisation to the industry.
The BBI global collaboration approach is based in a preliminary assessment and a feasibility analysis with the technology transfer offices teams or early-stage biotechnology-based companies followed by an international business development strategy with a private venture capital focus.
We use a unique educational approach for the organisational change with a learning focus in a high impact online methodology while we work together to design the appropriate approach towards a successful corporate strategy defining the key milestones. The different backgrounds from our advisors helps to have a customized strategy and plan design that can be implemented at a different management levels.
The Life Sciences sector is at an inflection point for disruptive change. To prepare for the future and remain relevant in the ever-evolving business landscape, biopharma and medical technology organisations will be looking for new ways to create value and respond to unmet medical need in a rapidly involving world. A new generation of management is needed to drive this change.
The BBI methodology for organisations is based in practical study cases and is an innovative tool that empowers global business to business interactions while reaching a parallel online educational result in form of a corporate strategy plans tailored to your actual needs.
After successfully passing the all the required evaluations and approval of the final business strategy, which is evaluated by a panel of industry experts, the organisations will receive a certificate awarded by the Biotechnology Business Institute as a form of international recognition of continuous professional development.
Here are some of the most frequent questions from our candidates
The BBI Business School has over 140 academics and industry experts, coming from more than 20 countries, who cover the key management topics in the Life Sciences industry: corporate finance; market access and healthcare economics, preclinical and clinical regulatory requirements, medical technologies, technology transfer and entrepreneurship, organisational behaviour and an understanding of the global strategy for new drug approvals.
The Biotechnology Business Institute (BBI) is an international business school focused on training a new generation of scientific managers and executives to prepare for their future careers. The BBI facilitates early-stage business development activities in partnership with the many stakeholders in the biotechnology sector and the pharmaceutical industry worldwide. A core focus is on new drug development to treat unmet medical need but also with broadening interests across the Life Sciences sector.
The Biotechnology Business Institute was founded to develop the next generation of talent in the international Life Sciences sector for scientists seeking to advance their careers in the pharmaceutical and biotechnology industries. We are committed to becoming a leading international academic institution in the management of Life Sciences, through enabling the career development of a new wave of global business leaders driving disruptive change throughout the ecosystem.
With a presence in two of the main innovation centres in Europe, Barcelona, and Cambridge, and the second largest market in the pharmaceutical industry in Latin America our students can choose which campus will best meet their needs.
As the International BBI headquarters, the Barcelona Campus is focused on drug discovery, built on a track record since 2013 delivering management programmes for scientists wanting to develop their careers in the global pharma & biotechnology industry.
The European headquarters, our Cambridge Campus, has a broader remit across the entire Life Science sector. At Cambridge, UK, our students can realise their objective of establishing a global network of contacts in the broader spectrum of commercial opportunities in Life Sciences.
BBI Mexico connects the pharmaceutical and biotechnology industry in Latin America with the major innovation hubs in Europe and the United States. It is the educational centre of reference in healthcare contributing to the development of national talent and the growth of national innovation promoting global transactions.
Know more about our campuses
The BBI network is formed by our alumni, the academic staff, lecturers, partner companies and the technology transfer offices who collaborate with us. Over the years, we have developed a community over 700 people globally in direct contact every year.
For more information, visit our BBI community Report